Patent No. EP3418379 (titled "Methods, Cells & Organisms") was filed by Kymab on Sep 18, 2014. The application was issued on Dec 9, 2020.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| REGENERON PHARMACEUTICALS | Dec 9, 2020 | STEINECKE |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
Jul 26, 2023
Jul 25, 2023
Jul 24, 2023
Jul 24, 2023
Jul 19, 2023
Jul 4, 2023
Jul 3, 2023
Jul 3, 2023
Jul 3, 2023
May 23, 2023
May 23, 2023
May 17, 2023
May 17, 2023
May 17, 2023
Mar 29, 2023
Mar 21, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 13, 2023
Mar 8, 2023
Mar 7, 2023
Mar 7, 2023
Mar 7, 2023
Mar 7, 2023
Mar 7, 2023
Mar 7, 2023
Mar 7, 2023
Jan 12, 2023
Jan 12, 2023
Jan 6, 2023
Jan 6, 2023
Jan 6, 2023
Jan 6, 2023
Jan 6, 2023
Jan 6, 2023
Jan 6, 2023
Jan 6, 2023
Jan 6, 2023
Jan 6, 2023
Jan 6, 2023
Jan 6, 2023
Jan 6, 2023
Jan 6, 2023
Jan 5, 2023
Nov 30, 2022
Nov 30, 2022
May 24, 2022
May 19, 2022
May 19, 2022
May 18, 2022
May 18, 2022
May 18, 2022
May 18, 2022
May 18, 2022
May 18, 2022
May 18, 2022
Feb 7, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Feb 1, 2022
Sep 23, 2021
Sep 23, 2021
Sep 14, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Sep 8, 2021
Jul 14, 2021
Jul 14, 2021
Dec 21, 2020
Dec 14, 2020
Dec 9, 2020
Dec 9, 2020
Dec 9, 2020
Nov 12, 2020
Oct 27, 2020
Jul 21, 2020
Jul 21, 2020
Jul 20, 2020
Jul 20, 2020
Jul 20, 2020
Jul 20, 2020
Jul 20, 2020
Jul 15, 2020
Jul 15, 2020
Jul 15, 2020
Jul 15, 2020
Jul 15, 2020
Jul 15, 2020
Jun 19, 2020
Jun 19, 2020
Jun 19, 2020
Jun 19, 2020
Jun 19, 2020
Jun 19, 2020
May 22, 2020
May 22, 2020
May 22, 2020
May 22, 2020
May 22, 2020
May 22, 2020
May 22, 2020
May 22, 2020
May 22, 2020
May 12, 2020
May 12, 2020
May 5, 2020
Aug 6, 2019
Aug 6, 2019
Aug 6, 2019
Aug 6, 2019
Aug 6, 2019
Feb 18, 2019
Jan 15, 2019
Jan 15, 2019
Jan 15, 2019
Jan 15, 2019
Nov 28, 2018
Oct 15, 2018
Oct 15, 2018
Oct 15, 2018
Oct 15, 2018
Oct 15, 2018
Oct 2, 2018
Aug 10, 2018
Aug 10, 2018
Aug 10, 2018
Aug 10, 2018
Jul 20, 2018
Jul 20, 2018
Jul 20, 2018
Jun 11, 2018
May 29, 2018
May 29, 2018
May 29, 2018
May 29, 2018
May 29, 2018
May 29, 2018
May 29, 2018
May 29, 2018
Apr 14, 2015
Apr 14, 2015